THE DEAL, AT A GLANCE
From the announcementDebut
01What it doesDebut is a million pre-clinical data points to find and discover new ingredients that address beauty consumer needs.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by L'OréalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedDebut raised $34M Series B, announced 2023-06-01From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersDebut's $34M Series B is a strategic, below-median Healthcare & Life Sciences financing led by L'Oréal, positioning the round as a targeted active-ingredients investment…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Debut · Financing Record
Explore source-linked visual explanations for Debut. Unsupported claims are withheld while source review continues.
Record 2855 · Recorded date: 2023-06-01
Explore company records →